![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 11, 8906-8911, March 15, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
¶
From the
Laboratory of Molecular Pharmacology, Center
for Cancer Research, NCI, National Institutes of Health, Bethesda,
Maryland 20892-4255 and § Section of Infectious Diseases,
Department of Medicine, Baylor College of Medicine, Houston,
Texas 77030
Received for publication, July 9, 2001, and in revised form, November 5, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Human nuclear DNA topoisomerase I (top1) plays a
crucial role in DNA replication, transcription, and chromosome
condensation. In this study, we show that intra- and intermolecular
guanosine quartets (G-quartets) can inhibit top1-mediated DNA cleavage
at a high affinity site. Top1-mediated DNA cleavage was also inhibited by a 16-mer single-stranded oligodeoxynucleotide (ODN) containing a
G-rich sequence
(G2T2G5TG2TG3)
and by its RNA equivalent, neither of which form G-quartet
structures. A comparison of various single-stranded ODN for their
ability to inhibit top1-mediated DNA cleavage indicated that G-rich
sequences containing repeats of 2 or 3 consecutive guanines interspaced
with thymines specifically inhibited top1. We also found that both
single-stranded and G-quartet-forming ODNs bind to top1 without being
cleaved by the enzyme. These results demonstrate that either DNA or RNA
G-rich single-stranded and G-quartet-forming oligonucleotides can bind
to top1 and prevent cleavage of duplex DNA.
DNA sequences containing a high percentage of guanine (G)
can form four-stranded structures referred to as G-quartets or
G-quadruplexes (for review see Ref. 1). Such sequences can be found in
telomeric regions (2), gene promoters (3, 4), and immunoglobulin switch
regions (5). G-quartet structures are made of G-stacked tetrads
corresponding to the planar association of guanines in a cyclic
Hoogsteen hydrogen-bonding arrangement (6, 7). Stacked tetrads are
stabilized by monovalent cations such as Na+ or
K+ (8). G-quartet structures have been proposed to play
important roles in transcription regulation, alignment of chromosome
pairs and telomerase activity. Several cellular proteins have been
reported to bind to G-quartet structures (9-15). Some of these
proteins, such as the Eukaryotic nuclear DNA topoisomerase I
(top1)1 is an ubiquitous and
multifunctional enzyme that regulates DNA topology during transcription, replication, chromosome condensation, and possibly recombination (for review see Refs. 21 and 22) by reversibly cleaving
one strand of duplex DNA and relaxing DNA supercoiling. For the
cleavage reaction, top1 forms a covalent 3'-phosphotyrosyl bond between
a tyrosine residue (Tyr-723 for human top1) and the 3'-end of the
broken DNA strand while leaving a 5'-hydroxyl terminus at the other end
of the cleaved DNA (23). Under normal conditions, the cleavage
complexes are rapidly reversible after relaxation of DNA supercoiling
(intramolecular reactions) and eventually DNA recombination
(intermolecular reactions). Top1 inhibitors, such as camptothecin and
its derivatives, selectively inhibit eukaryotic top1 by reversibly
preventing the religation step of the enzyme-mediated DNA
nicking-closing reaction (24, 25). Dissociation of the DNA strand 3'
from the cleavage site, due to the presence of a nick, gap, or
single-stranded branch in the vicinity, prevents the religation step of
top1 catalytic reaction (26) and leads to irreversible cleavage
complexes (27). Such substrates, commonly referred to as "suicide
substrates," have been very useful in the study of the top1 catalytic
cycle because they can be used to monitor, under single turnover
conditions, the top1-mediated DNA cleavage step (28, 29).
Because top1 has been reported to bind to noncanonical DNA structures
including three-stranded flaps, triple helical DNA, and Holliday
junctions (30-34), we investigated the effect of G-quartets and
various G-rich nucleic acids on top1 activity using purified recombinant human top1. A partially single-stranded 18-mer ODN, TH-18 (Fig. 1B), containing a high affinity site
(26, 35) (Fig. 1A) was used as a "suicide substrate"
(36). In this case, top1 becomes irreversibly bonded to the 3'-DNA
terminus, because a pentamer oligonucleotide (28, 29) dissociates and
therefore cannot be religated. This incomplete reaction leads to
a "suicide complex" (Fig. 1B).
Chemicals and Enzymes--
High pressure liquid
chromatography-purified oligonucleotides were purchased from Bioserve
Biotechnologies (Laurel, MD) and high pressure
stopped-flow-purified oligonucleotides from MGW Biotech Inc. (High
Point, NC). [ Oligonucleotide Labeling and Annealing--
3'-End-labeling was
performed using terminal deoxynucleotidyl transferase (Invitrogen) with
[ Intramolecular G-quartet Formation--
Intramolecular G-quartet
structures were prepared as described previously (15). Briefly,
oligonucleotides at 5 µM strand equivalent were heated at
90 °C for 5 min in 20 mM Li3PO4,
pH 7.0 and then cooled at 4 °C for 30 min in the presence of 10 mM KCl. Intramolecular G-quartet formation was checked by
thermal denaturation and circular dichroism experiments (15). Further dilutions of the intramolecular G-quartet oligonucleotides were performed in 10 mM KCl.
Intermolecular G-quartet Formation--
Intermolecular G-quartet
structures were prepared as described previously (19) with the
following modifications. 20 nM of 5'-end labeled
single-stranded oligonucleotide was incubated for 72 h at room
temperature with the same unlabeled strand (10 mM ) in a
buffer containing 10 mM Tris-HCl, pH 7.5, and 1 M NaCl. Intermolecular G-quartet formation was checked by
gel shift assay (19). Samples were diluted 1:10 with 10 mM
Tris-HCl, pH 7.5, 10 mM KCl, and 1 mM EDTA
prior to the addition of 0.5 volume of nondenaturing dye (30 mM Tris-HCl, pH 7.5, 10 mM KCl, 1 mM EDTA, 1 mg/ml bromphenol blue, and 30% glycerol). The
samples were then loaded on an 8% polyacrylamide native gel (29:1) run
in 0.5× TBE (100 mM Tris-HCl, pH 8.4, 90 mM
boric acid, and 1 mM EDTA) and 10 mM KCl.
Electrophoresis was performed at 4 °C and 5 V/cm for 3 h.
Top1 Suicide Reaction--
The suicide cleavage reactions were
performed as described previously (36). Briefly, 5 pmol of recombinant
top 1 were preincubated with the G-rich oligonucleotide for 5 min at
room temperature in a buffer containing 10 mM Tris-HCl, pH
7.5, 50 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 15 µg/ml of bovine serum albumin, and 0.2 mM dithiothreitol. Irreversible top1-mediated DNA cleavage
reaction was initiated by addition of 25 fmol of 3'-end labeled
TH-18 DNA substrate in a total volume of 10 µl, and the
samples were incubated for 15 min at room temperature. Reactions
were stopped by adding 0.5 volume of denaturing loading dye (100%
formamide, 1 mg/ml bromphenol blue, and 1 mg/ml xylene cyanol blue),
and the samples were loaded on a 20% (19:1) polyacrylamide gel
containing 7 M urea and 1× TBE.
CPT-induced DNA Cleavage Sites in the pSK Fragment--
A 202-bp
DNA fragment was generated by PCR from the pBluescript SK( Top1 Binding Assay--
10 pmol of recombinant top 1 was
incubated for 30 min at room temperature with 25 fmol of 3'-end-labeled
DNA substrate in a buffer containing 50 mM Tris-HCl, pH
7.5, and 50 mM NaCl in a total volume of 10 µl. The
samples were treated with 0.5 volume of nondenaturing loading dye (30 mM Tris-HCl, pH 7.5, 1 mg/ml bromphenol blue, and 30%
glycerol), loaded on a 6% (19:1) polyacrylamide gel containing 0.5×
TBE, and electrophoresed at 4 °C, 100 V for 2 h.
Imaging and quantitation of the gels were performed using a
PhosphorImager (Molecular Dynamics, Sunnyvale, CA).
Intramolecular G-quartets Inhibit top1-mediated DNA
Cleavage--
We first studied the influence of two well characterized
G-quartet-forming ODNs (T30923 and T40216) (15)
on top1-mediated DNA cleavage (Fig. 2A). Both
oligonucleotides inhibited top1 cleavage activity at low nanomolar
concentrations (Fig. 2A). The oligonucleotide T40216 was more potent than T30923, suggesting
that the length of the quartet could play a role in the inhibitory
effect (Fig. 2B). T40216 was only 3 to 4 times
less potent (Fig. 2B) than the high affinity full duplex
substrate TH-36 (Fig.
1A), which competed with the
labeled suicide substrate (final concentration 2.5 nM) and
inhibited 50% of top1 cleavage (defined as IC50) at ~6
nM (Fig. 2B).
These results demonstrate that top1-mediated DNA cleavage can be
inhibited at low nanomolar concentrations by intramolecular G-quartet
ODNs.
Intermolecular G-quartets Inhibit top1-mediated DNA
Cleavage--
Because we observed that top1 can be inhibited by
intramolecular G-quartets, we next investigated the effect of
intermolecular G-quartet structures on top1-mediated DNA cleavage. We
chose a 30-mer G-rich single-stranded oligonucleotide
[ODN-1] (Fig. 3A)
derived from the yeast telomeric sequence of Saccharomyces cerevisiae. This oligonucleotide can form an intermolecular
parallel G-quartet (19) for which formation can be monitored by gel
electrophoresis (Fig. 3B). Both single-stranded
[ODN-1:SS] and quadruplex [ODN-1:G4]
conformations were tested (Fig. 3C). The intermolecular G-quartet inhibited top1-mediated DNA cleavage with an IC50
of ~100 nM, which is higher than for the intramolecular
G-quartets T30963 and T40216 (2- and 5-fold,
respectively, compare Figs. 3B and 2B).
Interestingly, ODN-1:SS was also active with an
IC50 ~3 times higher than ODN-1:G4 (Fig. 3,
B and C). These results demonstrate that
intermolecular G-quartets can also inhibit top1-mediated DNA cleavage
at a high affinity site in duplex DNA.
A Single-stranded 16-mer G-rich ODN Inhibits top1-mediated DNA
Cleavage--
We next investigated whether a G-quartet-forming
structure or a sequence containing consecutive guanosines (G-stretch)
was sufficient to prevent top1 cleavage at its high affinity site. For
this purpose, we designed the oligonucleotide [ODN-2], which was derived from T30923 (Fig.
4A). ODN-2 has the same base content as T30923 (12 guanines and 4 thymines) but
cannot form either intra- or intermolecular G-quartets as verified by gel mobility, thermal denaturation, and circular dichroism experiments (data not shown). Nevertheless, ODN-2 inhibited
top1-mediated DNA cleavage at low nanomolar concentration (Fig.
4B) and was as potent as the intramolecular G-quartets
T30963 and T40216 (see Fig. 2). ODN-2
was ~6-fold more efficient than its duplex homologue,
[ODN-2d], and was markedly more potent than its C-rich
complementary strand, [ODN-2c] (by at least 2 orders of
magnitude) (Fig. 4B). ODN-2 was also ~50-fold more potent than a non-G-rich single-stranded DNA of the same length,
corresponding to the last 16 bases of HIV-1 U5 long terminal repeat
sequence [ODN-3]. These results demonstrate that the
single-stranded G-rich oligonucleotide ODN-2 effectively inhibits DNA cleavage.
DNA Sequence Specificity of G-rich Single-stranded ODNs--
To
further investigate the influence of the guanine distribution in
single-stranded oligonucleotides, different G-rich sequences were
tested (Fig. 5A). In the
oligonucleotide ODN-5, one of the thymines was moved in
order to disrupt the G-stretch present in the middle of
ODN-2 (Fig. 5A). ODN-5 showed
approximately the same potency as ODN-2 (Fig.
5B), indicating that the 5-mer G-stretch present in the
middle of ODN-2 is not required for top1 inhibition.
Consistent with this observation, we found that an oligonucleotide
containing only a central stretch of guanosines flanked by one thymine,
[ODN-10], only inhibited top1-mediated DNA cleavage above
micromolar concentrations (Fig. 5B).
The presence and position of the thymines in ODN-2 were then
investigated by placing two of the four thymines at both extremities of
the sequence. ODN-6 was ~5-fold less potent than
ODN-2 (Fig. 5B). This difference increased to
~15-fold when the thymines were replaced by four guanines in the
poly-G ODN-7, demonstrating the importance of the thymines
for activity.
To investigate whether top1 cleavage could be inhibited by
5'-TpG-3' steps, which represent high affinity sites for human top1 in
duplex DNA (28, 41, 42), a 16-mer ODN with an alternating TG sequence,
[ODN-8], was tested. This oligonucleotide was ~150-fold
less potent than ODN-2. Weak activity was also observed for
a 16-mer oligonucleotide formed by four TTGG repeats,
[ODN-9]. These results demonstrate the importance of the
DNA sequence of G-rich single-stranded ODNs for top1-mediated DNA
cleavage inhibition.
G-quartet-forming and G-rich Single-stranded ODNs Inhibit
Camptothecin-induced top1 Trapping on DNA--
We next tested the
effect of G-rich ODNs on camptothecin-induced top1 trapping on DNA. We
performed these experiments with the
PvuII-HindIII digested pBluescript SK( G-rich Single-stranded and G-quartet-forming ODNs Both Bind to
top1--
Gel shift experiments were performed to determine top1
binding to the G-rich single-stranded ODN-2 and to the
G-quartet forming oligonucleotides (T30923 & T40216). These three substrates produced a band with
retarded electrophoretic mobility when incubated with purified top1
(Fig. 7A). Binding
efficiencies for these oligonucleotides were lower than for
TH-36.
The G-rich Single-stranded ODN-2 Displaces top1 from Its High
Affinity Substrate--
To investigate further the binding of G-rich
oligonucleotides to top1, competition experiments were performed in the
presence of both the high affinity duplex TH-36 and
ODN-2. In these experiments, a DNA-protein complex was
formed between top1 and 32P-labeled TH-36 in the
presence of increasing concentrations of unlabeled ODN-2 or
unlabeled TH-36 (Fig. 7B). At high concentrations of unlabeled oligonucleotide, the band corresponding to the
top1-labeled TH-36 complex on the gel disappeared for both
ODN-2 and TH-36. This indicates that both
oligonucleotides displaced top1 from its labeled substrate
(TH-36). The efficiency of strand displacement was ~10
times lower for ODN-2 than for TH-36 (Fig.
7B). Furthermore, in the experiments including both
TH-36 and ODN-2, we did not observe any
supershift of the top1-DNA band suggesting that top1 binds either to
its duplex high affinity substrate TH-36 or to the
single-stranded G-rich ODN-2 but not to both at the same
time. These results demonstrate that G-rich oligonucleotides can bind
competitively to top1 and prevent the enzyme from cleaving duplex DNA.
G-quartet-forming and G-rich Single-stranded ODNs Are Not top1
Substrates--
To determine whether the G-quartets and G-rich
single-stranded ODNs could be substrates for top1, the G-rich ODNs were
labeled and tested for top1-mediated DNA cleavage. As expected,
camptothecin induced cleavage in the TH-36 ODN (see Fig.
1A for sequence). Camptothecin also enhanced cleavage in the
suicide TH-18 ODN, indicating that top1-mediated DNA
cleavage in this oligonucleotide is partially reversible. Using
ODN-2, cleavage was not detected either in the absence or
presence of camptothecin (Fig. 8). A
similar result was obtained with the G-quartet ODNs T30923 and T40216 (data not shown), demonstrating that these G-rich
ODNs are not cleaved by top1.
The RNA Equivalent of ODN-2 Also Inhibits top1-mediated
DNA Cleavage--
We next tested the effect of single-stranded RNA on
the inhibition of top1-mediated DNA cleavage. First we designed an
oligodeoxynucleotide identical to ODN-2 in which thymines
were replaced by uracils (Fig.
9A). ODN-11
inhibited top1 DNA-mediated cleavage (Fig. 9B) and was
~4-fold less potent than the parental ODN-2. The RNA
equivalent of ODN-11, [ORN-12] (Fig.
9A), was ~2-fold more potent than its ODN homologue (Fig.
9, B and C). Thus, top1-mediated DNA cleavage can
be efficiently inhibited by single-stranded G-rich RNA.
The present study demonstrates that both intra- and intermolecular
G-quartets and single-stranded G-rich ODNs inhibit top1-mediated DNA
cleavage. This inhibition appears to require repeats of at least 2~3
consecutive guanines interspaced with thymines. We also demonstrate
that the inhibition of top1-mediated DNA cleavage can be efficiently
achieved with G-rich RNA and that the G-quartet-forming and
single-stranded G-rich ODNs bind competitively to top1 without being
cleaved by the enzyme.
It is becoming increasingly clear that top1 can bind to noncanonical
DNA structures. DNA containing partially single-stranded regions and
extra-helical segments (bulges) were shown to be cleaved by the enzyme
(26, 43, 44). Top1 also cleaves DNA sites with local structure
distortion including oxidative base modifications (36), base mismatches
and abasic sites (45), UV photoproducts (46), base methylation (47),
intercalation (48), and minor groove alkylation (49, 50). Top1 has also
been found to cleave three-stranded flap regions and promote their DNA
recombination (30, 31). Top1 binding to triple helical DNA has also
been reported (32) as well as binding to Holliday junctions, which correspond to four-stranded structures as in the case of G-quartets (33, 34). However in contrast to the Holliday junctions, the G-quartets
we examined are not cleaved by top1. More recently, Hélène and co-workers (51) also reported that top1
binds to preformed inter- and intramolecular G-quartets and promotes
the opening of a 69-bp duplex to form a stable intermolecular
G-quartet-containing structure. It is therefore intriguing how top1 can
bind to such diverse structures. Recently the structure of top1 bound
covalently and noncovalently to duplex DNA has been determined, and the
enzyme has been shown to encircle the DNA duplex (52, 53). The finding that top1 can also bind to G-rich single-stranded and four-stranded DNA
suggests that the enzyme can accommodate various size nucleic acids.
High affinity binding of top1 to single-stranded DNA or RNA has not
been reported previously. In fact, binding to nonspecific single-stranded DNA with random sequence was weak (54) and was detectable only in segments that had the potential to form duplex structures (55). Top1 is known to play an important role in transcription (for review see Ref. 56) by direct binding to transcription complexes (57-60) and phosphorylation of serine-arginine rich (SR) splicing factors that control pre-mRNA splicing (61). Top1 enhances TFIID-TFIIA complex assembly during activation of transcription (62) and interacts with TFIIIC to promote accurate termination and reinitiation (63). In this work, we report top1 inhibition by G-rich-containing RNA oligonucleotides. The in
vivo significance of top1 binding to T- and G-rich single-stranded RNA still remains to be determined, but it is possible that top1 could
play a role in the stabilization of such sequences during transcription, preventing their folding into higher order structures. Top1 binding to T- and G-rich single-stranded RNA might contribute to
the activity of the enzyme in RNA splicing (64, 65). These results
point to top1 being a multifunctional enzyme capable of accommodating
varied DNA structures.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-subunit of the Oxytricha
telomere-binding protein (9) and RAP1 (repressor activator protein 1 (16)) promote G-quartet formation. Conversely, helicases such as the
simian virus 40 (SV40) large T-antigen (17), the Bloom's syndrome
helicase (Blm (18)), the subgenomic segment 1 helicase (Sgs1 (19)), and
the Werner syndrome helicase (Wrn (20)) have been shown to unwind
G-quartet structures in vitro.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]Cordycepin 5'-triphosphate was
purchased from PerkinElmer Life Sciences. Polyacrylamide gel
solutions were from National Diagnostics (Atlanta, GA). Human
N-terminal truncated recombinant top1 (68 kDa) was expressed and
purified essentially as reported previously (37). Briefly, the top1
gene was cloned into a baculovirus transfer vector (pBacGus-1, Novagen,
Madison, WI) and used to make a recombinant baculovirus following the
manufacturer's recommendations (BD-PharMingen, San Diego, CA). Top1
protein was then expressed in TN5 insect cells (HighFive, Invitrogen)
by the recombinant baculovirus and purified via the N-terminal His tag
essentially as described (26, 38).
-32P]cordycepin 5'-triphosphate as described
previously (39). The oligonucleotides were annealed in a buffer
containing 10 mM Tris-HCl, pH 7.5, and 5 mM
MgCl2 by heating for 5 min at 95 °C and cooling 30 min
at 37 °C.
) phagemid
(Stratagene, La Jolla, CA) using the following primers: forward
(514-534), 5'-GCCTCTTCGCTATTACGCCAG-3'; and reverse (693-716),
5'-GGCTGCAGGAATTCGATATCAAGC-3'. The PCR product was gel-purified using
the QIAEX II Gel Purification System (Qiagen, Valencia, CA) and
digested by HindIII. The resulting 177-bp DNA fragment was
3'-end labeled as described previously (40), resuspended in water, and
used at ~50 nmol/reaction (50,000 dpm). Reaction conditions were
identical to the ones used in the suicide reaction except for the
addition of camptothecin (see above).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (17K):
[in a new window]
Fig. 1.
Schematic representation of the suicide
complex reaction. A, the TH-36 ODN
corresponds to the duplex oligonucleotide containing a high affinity
cleavage site for top1 (inverted black triangle).
B, in the top1 suicide reaction, an 18-mer ODN
(TH-18) is 3'-end-labeled by incorporation of
[
-32P]cordycepin 5'-triphosphate in the presence of
terminal transferase. The labeled product is a 19-mer ODN (including
the labeled cordycepin nucleotide shown in italics and
marked by an asterisk). This ODN is annealed to a 36-mer
complementary strand. Top1 recognizes its high affinity site, cleaves
the upper strand, and liberates a 5-mer 3'-end-labeled ODN that
separates from the uncleaved strand on a denaturing gel. Top1 remains
bound at the 3' extremity of the cleaved strand (suicide
complex).

View larger version (31K):
[in a new window]
Fig. 2.
Inhibition of top1 cleavage by intramolecular
G-quartet ODNs. A, schematic representation of the
G-quartet ODNs. B, PhosphorImager representation of a
typical experiment. Lanes 0, DNA plus top1. The
concentrations of the G-quartet ODNs were: lanes 1, 4.5 nM; lanes 2, 13.7 nM; lanes
3, 41 nM; lanes 4, 123 nM; and
lanes 5, 370 nM. C, densitometric
analysis of the gel shown in B. Circles,
T30923; squares, T40216;
triangles, TH-36.

View larger version (37K):
[in a new window]
Fig. 3.
Inhibition of top1 cleavage by yeast
telomeric sequence both as intermolecular G-quartet and as
single-stranded DNA. A, sequence of the ODNs tested.
B, PhosphorImager representation of the intermolecular
G-quartet formation. C, PhosphorImager representation of a
typical experiment. Lanes 0, DNA alone; lanes 1,
DNA plus top1. The concentrations in ODN-1 were: lanes
2, 4.5 nM; lanes 3, 13.7 nM;
lanes 4, 41 nM; lanes 5, 123 nM; lanes 6, 370 nM; lanes
7, 1,111 nM; lanes 8, 3,333 nM;
and lanes 9, 10,000 nM. D,
densitometric analysis of the gel shown in C. Circles, ODN-1:SS; squares,
ODN-1:G4.

View larger version (21K):
[in a new window]
Fig. 4.
Inhibition of top1 cleavage by a G-rich
single-stranded ODN. A, sequences of the ODNs
tested. B, densitometric analysis of a typical
PhosphorImager picture (not shown). Circles,
ODN-2; triangles, ODN-2d;
squares, ODN-3; inverted triangles,
ODN-2c.

View larger version (28K):
[in a new window]
Fig. 5.
Sequence-specific inhibition of top1-mediated
DNA cleavage by G-rich single-stranded ODNs. A,
sequences of the ODNs tested. B, densitometric
analysis of a typical PhosphorImager picture (not shown).
Circles, ODN-2; diamonds,
ODN-5; squares, ODN-6;
crosses, ODN-7; inverted triangles,
ODN-8; circled dot, ODN-9;
triangles, ODN-10.
) 177-bp
DNA fragment, which contains previously characterized top1 cleavage
sites (40). Fig. 6 shows that both
oligonucleotides T30923 and ODN-2 inhibited the
camptothecin-induced DNA cleavage at all sites examined. As in the case
of the TH-18 suicide substrate, ODN-2 was more
potent than T30923 (Fig. 6).

View larger version (53K):
[in a new window]
Fig. 6.
Inhibition of camptothecin-induced top1
cleavage by G-quartet and G-rich single-stranded ODNs. The 177-bp
pBluescript SK(
) fragment was generated by PCR and labeled as
described previously (40). Camptothecin (CPT) was used at 10 µM to block top1-mediated religation and therefore reveal
top1 cleavage sites.

View larger version (36K):
[in a new window]
Fig. 7.
Competitive binding of top1 to G-quartet and
G-rich single-stranded ODNs. A, PhosphorImager
representation of a nondenaturing gel. B, densitometric
analysis of a competition experiment. Squares,
TH-36; circles, ODN-2.

View larger version (78K):
[in a new window]
Fig. 8.
The G-rich single-stranded ODN-2 is not
cleaved by top1. The 3'-end-labeled substrates are indicated at
the top. Camptothecin (CPT) was used at 1 µM to reveal the top1 high affinity site (see Fig.
1).

View larger version (34K):
[in a new window]
Fig. 9.
Inhibition of top1-mediated DNA cleavage by
single-stranded G-rich ORNs. A, sequence of the
oligodeoxynucleotide [ODN-11] and oligoribonucleotide
[ODN-12] tested. B, PhosphorImager
representation of a typical experiment. Lanes 0, DNA alone;
lanes 1, DNA plus top1. The concentrations of the
oligonucleotides were: lanes 2, 0.45 nM;
lanes 3, 1.37 nM; lanes 4, 4.1 nM; lanes 5, 12.3 nM; lanes
6, 37 nM; lanes 7, 111 nM;
lanes 8, 333 nM; lanes 9, 1000 nM. C, densitometric analysis of the gel shown
in B. Circles, ODN-11;
squares, ORN-12.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Laboratory of Molecular Pharmacology, Center for Cancer Research, Bldg. 37, Rm. 5068, NCI, National Institutes of Health, Bethesda, MD 20892-4255. Tel.: 301-496-5944; Fax: 301-402-0752; E-mail: pommier@nih.gov.
Published, JBC Papers in Press, December 26, 2001, DOI 10.1074/jbc.M106372200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: top1, topoisomerase I; ODN, oligodeoxynucleotide; ORN, oligoribonucleotide; TF, transcription factor.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Han, H. Y., and Hurley, L. H. (2000) Trends Pharmacol. Sci. 21, 136-142[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Blackburn, E. H., and Szostak, J. W. (1984) Annu. Rev. Biochem. 53, 163-194[CrossRef][Medline] [Order article via Infotrieve] |
| 3. |
Evans, T.,
Schon, E.,
Goramaslak, G.,
Patterson, J.,
and Efstratiadis, A.
(1984)
Nucleic Acids Res.
12,
8043-8058 |
| 4. | Kilpatrick, M. W., Torri, A., Kang, D. S., Engler, J. A., and Wells, R. D. (1986) J. Biol. Chem. 261, 1350-1354 |
| 5. | Shimizu, A., and Honjo, T. (1984) Cell 36, 801-803[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Sen, D., and Gilbert, W. (1988) Nature 334, 364-366[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Sundquist, W. I., and Klug, A. (1989) Nature 342, 825-829[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Williamson, J. R., Raghuraman, M. K., and Cech, T. R. (1989) Cell 59, 871-880[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Fang, G. W., and Cech, T. R. (1993) Cell 74, 875-885[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Weismanshomer, P.,
and Fry, M.
(1993)
J. Biol. Chem.
268,
3306-3312 |
| 11. | Giraldo, R., and Rhodes, D. (1994) EMBO J. 13, 2411-2420[Medline] [Order article via Infotrieve] |
| 12. |
Erlitzki, R.,
and Fry, M.
(1997)
J. Biol. Chem.
272,
15881-15890 |
| 13. |
Sarig, G.,
Weisman-Shomer, P.,
Erlitzki, R.,
and Fry, M.
(1997)
J. Biol. Chem.
272,
4474-4482 |
| 14. |
Dempsey, L. A.,
Sun, H.,
Hanakahi, L. A.,
and Maizels, N.
(1999)
J. Biol. Chem.
274,
1066-1071 |
| 15. |
Jing, N. J.,
Marchand, C.,
Liu, J.,
Mitra, R.,
Hogan, M. E.,
and Pommier, Y.
(2000)
J. Biol. Chem.
275,
21460-21467 |
| 16. |
Giraldo, R.,
Suzuki, M.,
Chapman, L.,
and Rhodes, D.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7658-7662 |
| 17. |
Baran, N.,
Pucshansky, L.,
Marco, Y.,
Benjamin, S.,
and Manor, H.
(1997)
Nucleic Acids Res.
25,
297-303 |
| 18. |
Sun, H.,
Karow, J. K.,
Hickson, I. D.,
and Maizels, N.
(1998)
J. Biol. Chem.
273,
27587-27592 |
| 19. |
Sun, H.,
Bennett, R. J.,
and Maizels, N.
(1999)
Nucleic Acids Res.
27,
1978-1984 |
| 20. |
Fry, M.,
and Loeb, L. A.
(1999)
J. Biol. Chem.
274,
12797-12802 |
| 21. | Gupta, M., Fujimori, A., and Pommier, Y. (1995) Biochim. Biophys. Acta 1262, 1-14[Medline] [Order article via Infotrieve] |
| 22. | Wang, J. C. (1996) Annu. Rev. Biochem. 65, 635-692[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Champoux, J. J.
(1981)
J. Biol. Chem.
256,
4805-4809 |
| 24. | Chen, A. Y., and Liu, L. F. (1994) Annu. Rev. Pharmacol. Toxicol. 94, 194-218 |
| 25. | Pommier, Y. (1996) Semin. Oncol. 23, 1-10[Medline] [Order article via Infotrieve] |
| 26. |
Pourquier, P.,
Pilon, A. A.,
Kohlhagen, G.,
Mazumder, A.,
Sharma, A.,
and Pommier, Y.
(1997)
J. Biol. Chem.
272,
26441-26447 |
| 27. | Pourquier, P., and Pommier, Y. (2001) Adv. Cancer Res. 80, 189-216[Medline] [Order article via Infotrieve] |
| 28. | Svejstrup, J. Q., Christiansen, K., Gromova, I. I., Andersen, A. H., and Westergaard, O. (1991) J. Mol. Biol. 222, 669-678[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Shuman, S.
(1991)
J. Biol. Chem.
266,
1796-1803 |
| 30. |
Pourquier, P.,
Jensen, A. D.,
Gong, S. S.,
Pommier, Y.,
and Rogler, C. E.
(1999)
Nucleic Acids Res.
27,
1919-1925 |
| 31. |
Cheng, C. H.,
and Shuman, S.
(2000)
Mol. Cell. Biol.
20,
8059-8068 |
| 32. | Arimondo, P. B., Moreau, P., Boutorine, A., Bailly, C., Prudhomme, M., Sun, J. S., Garestier, T., and Hélène, C. (2000) Bioorg. Med. Chem. 8, 777-784[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Sekiguchi, J.,
Seeman, N. C.,
and Shuman, S.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
785-789 |
| 34. |
Sekiguchi, J.,
Cheng, C. H.,
and Shuman, S.
(2000)
Nucleic Acids Res.
28,
2658-2663 |
| 35. | Bonven, B. J., Gocke, E., and Westergaard, O. (1985) Cell 41, 541-551[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Pourquier, P.,
Ueng, L. M.,
Fertala, J.,
Wang, D.,
Park, H. J.,
Essigmann, J. M.,
Bjornsti, M. A.,
and Pommier, Y.
(1999)
J. Biol. Chem.
274,
8516-8523 |
| 37. |
Pourquier, P.,
Takebayashi, Y.,
Urasaki, Y.,
Gioffre, C.,
Kohlhagen, G.,
and Pommier, Y.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1885-1890 |
| 38. | Zhelkovsky, A. M., Moore, C. L., Rattner, J. B., Hendzel, M. J., Furbee, C. S., Muller, M. T., and Bazett-Jones, D. P. (1994) Protein Expression Purif. 5, 364-370[CrossRef][Medline] [Order article via Infotrieve] |
| 39. | Pommier, Y., Jenkins, J., Kohlhagen, G., and Leteurtre, F. (1995) Mutat. Res. 337, 135-145[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Cushman, M., Jayaraman, M., Vroman, J. A., Fukunaga, A. K., Fox, B. M., Kohlhagen, G., Strumberg, D., and Pommier, Y. (2000) J. Med. Chem. 43, 3688-3698[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Been, M. D.,
Burgess, R. R.,
and Champoux, J. J.
(1984)
Nucleic Acids Res.
12,
3097-3114 |
| 42. |
Porter, S. E.,
and Champoux, J. J.
(1989)
Mol. Cell. Biol.
9,
541-550 |
| 43. | Henningfeld, K. A., and Hecht, S. (1995) Biochemistry 34, 6120-6129[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Wang, X., Henningfeld, K. A., and Hecht, S. M. (1998) Biochemistry 37, 2691-2700[CrossRef][Medline] [Order article via Infotrieve] |
| 45. |
Pourquier, P.,
Ueng, L. M.,
Kohlhagen, G.,
Mazumder, A.,
Gupta, M.,
Kohn, K. W.,
and Pommier, Y.
(1997)
J. Biol. Chem.
272,
7792-7796 |
| 46. |
Lanza, A.,
Tornatelli, S.,
Rodolfo, C.,
Scanavini, M. C.,
and Pedrini, A. M.
(1996)
J. Biol. Chem.
271,
6978-6986 |
| 47. |
Leteurtre, F.,
Kohlhagen, G.,
Fesen, M. R.,
Tanizawa, A.,
Kohn, K. W.,
and Pommier, Y.
(1994)
J. Biol. Chem.
269,
7893-7900 |
| 48. |
Pommier, Y.,
Laco, G. S.,
Kohlhagen, G.,
Sayer, J. M.,
Kroth, H.,
and Jerina, D. M.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
10739-10744 |
| 49. |
Takebayashi, Y.,
Pourquier, P.,
Yoshida, A.,
Kohlhagen, G.,
and Pommier, Y.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7196-7201 |
| 50. |
Pommier, Y.,
Kohlhagen, G.,
Pourquier, P.,
Sayer, J. M.,
Kroth, H.,
and Jerina, D. M.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2040-2045 |
| 51. |
Arimondo, P. B.,
Riou, J. F.,
Mergny, J. L.,
Tazi, J.,
Sun, J. S.,
Garestier, T.,
and Hélène, C.
(2000)
Nucleic Acids Res.
28,
4832-4838 |
| 52. |
Redinbo, M. R.,
Stewart, L.,
Kuhn, P.,
Champoux, J. J.,
and Hol, W. G. J.
(1998)
Science
279,
1504-1513 |
| 53. | Redinbo, M. R., Champoux, J. J., and Hol, W. G. J. (2000) Biochemistry 39, 6832-6840[CrossRef][Medline] [Order article via Infotrieve] |
| 54. |
Jaxel, C.,
Capranico, G.,
Kerrigan, D.,
Kohn, K. W.,
and Pommier, Y.
(1991)
J. Biol. Chem.
266,
20418-20423 |
| 55. | Been, M. D., and Champoux, J. J. (1984) J. Mol. Biol. 180, 515-531[CrossRef][Medline] [Order article via Infotrieve] |
| 56. | Tazi, J., Rossi, F., Labourier, E., Gallouzi, I., Brunel, C., and Antoine, E. (1997) J. Mol. Med. 75, 786-800[CrossRef][Medline] [Order article via Infotrieve] |
| 57. | Merino, A., Madden, K. R., Lane, W. S., Champoux, J. J., and Reinberg, D. (1993) Nature 365, 227-232[CrossRef][Medline] [Order article via Infotrieve] |
| 58. |
Kretzschmar, M.,
Meisterernst, M.,
and Roeder, R. G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11508-11512 |
| 59. |
Straub, T.,
Grue, P.,
Uhse, A.,
Lisby, M.,
Knudsen, B. R.,
Tange, T. O.,
Westergaard, O.,
and Boege, F.
(1998)
J. Biol. Chem.
273,
26261-26264 |
| 60. |
Edwards, T. K.,
Saleem, A.,
Shaman, J. A.,
Dennis, T.,
Gerigk, C.,
Oliveros, E.,
Gartenberg, M. R.,
and Rubin, E. H.
(2000)
J. Biol. Chem.
275,
36181-36188 |
| 61. | Rossi, F., Labourier, E., Forne, T., Divita, G., Derancourt, J., Riou, J. F., Antoine, E., Cathala, G., Brunel, C., and Tazi, J. (1996) Nature 381, 80-82[CrossRef][Medline] [Order article via Infotrieve] |
| 62. |
Shykind, B. M.,
Kim, J.,
Stewart, L.,
Champoux, J. J.,
and Sharp, P. A.
(1997)
Genes Dev.
11,
397-407 |
| 63. | Wang, Z. X., and Roeder, R. G. (1998) Mol. Cell. 1, 749-757[CrossRef][Medline] [Order article via Infotrieve] |
| 64. |
Rossi, F.,
Labourier, E.,
Gallouzi, I. E.,
Derancourt, J.,
Allemand, E.,
Divita, G.,
and Tazi, J.
(1998)
Nucleic Acids Res.
26,
2963-2970 |
| 65. |
Labourier, E.,
Rossi, F.,
Gallouzi, I. E.,
Allemand, E.,
Divita, G.,
and Tazi, J.
(1998)
Nucleic Acids Res.
26,
2955-2962 |
This article has been cited by other articles:
![]() |
N. Jing, Q. Zhu, P. Yuan, Y. Li, L. Mao, and D. J. Tweardy Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer. Mol. Cancer Ther., February 1, 2006; 5(2): 279 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Antony, P. B. Arimondo, J.-S. Sun, and Y. Pommier Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures Nucleic Acids Res., October 4, 2004; 32(17): 5163 - 5173. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jing, Y. Li, W. Xiong, W. Sha, L. Jing, and D. J. Tweardy G-Quartet Oligonucleotides: A New Class of Signal Transducer and Activator of Transcription 3 Inhibitors That Suppresses Growth of Prostate and Breast Tumors through Induction of Apoptosis Cancer Res., September 15, 2004; 64(18): 6603 - 6609. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||